Stem Cells for ALS Treatment

Stem Cells for ALS Treatment: Why Patients Choose Regencord in Pereira

Patients seeking a new ALS treatment can access stem cell therapy in Colombia for $8,000 to $15,000, while Western countries charge $20,000 to $50,000. These cost savings make Colombia one of the most important destinations for cutting-edge medical treatments, especially for those with neurodegenerative disease needs.

Colombian healthcare facilities provide stem cells for ALS treatment at prices 50-70% lower than U.S. and European rates. The quality and expertise remain top-notch. Regencord in Pereira stands out globally as a stem cell therapy center. They deliver outstanding care with proven results. This piece explores how Regencord’s ALS treatment approach combines affordability with world-class medical expertise.

Before After

The Science Behind Stem Cells for ALS Treatment

“The premise of stem cell therapy for ALS aims to improve the diseased microenvironment. While stem cells are unable to replace diseased motor neurons directly, transplanted stem cells secrete neurotrophic factors and differentiate into supportive cells, such as astrocytes and microglia, generating a neuroprotective milieu that can slow degeneration of motor neurons.” — Stephen A. Goutman, Director of the Pranger ALS Clinic at the University of Michigan

Scientists are discovering how stem cell research for ALS might slow down disease progression through regenerative medicine. Traditional treatments only manage symptoms, but stem cell therapy targets the root cause of nerve cell degeneration that drives this neurodegenerative disease.

Types of Stem Cells Used in ALS Therapy

Scientists use several types of stem cells to treat ALS. Each type has unique characteristics:

Adult stem cells (endogenous) - These cells live in specific tissues like bone marrow and parts of the central nervous system. They can only turn into certain cell types.
Embryonic stem cells - Scientists get these from early-stage embryos. They can develop into any type of cell.
Induced pluripotent stem cells (iPSCs) - These are adult cells reprogrammed to act like embryonic stem cells. Scientists use them to create motor neurons for research and disease modeling.
Mesenchymal stem cells (MSCs) - Scientists use these stem cells most often in ALS clinical trials. They come from bone marrow, fat tissue, and umbilical cord blood.

MSCs lead the pack in ALS treatment research because labs can grow them easily, and they release helpful compounds like transforming growth factor-beta and vascular endothelial growth factor (VEGF). Neural progenitor cells (NPCs) also show great promise because they can become supportive glial cells.

Mechanism of Action in Motor Neuron Protection

Stem cells protect motor neurons instead of replacing damaged ones. These transplanted cells release special proteins called trophic factors that support and protect neurons. One protein, glial cell line-derived neurotrophic factor (GDNF), stands out for its ability to protect motor neurons from breaking down.

These cells also help control the immune system and reduce harmful inflammation in the central nervous system. This matters because inflammation speeds up ALS progression. MSCs also change the environment around motor neurons. They suppress microglial activation and reduce astrogliosis - two key factors in ALS progression.

A recent phase 1/2 clinical trial in 2022 showed that neural progenitors placed in the lumbar spinal cord could become supportive glial cells that produce GDNF. Another analysis from 2023 revealed even more promising results. Patients who received MSC transplants lived an average of 118.8 months—almost 10 years. This was much longer than the expected 70.79 months.

Delivery Methods and Their Effectiveness

The way doctors deliver stem cells makes a big difference in how well the treatment works. Scientists have developed several approaches:

Intraspinal injection puts cells right where they're needed. Clinical trials show this method can slow disease progression after lumbar procedures. The procedure carries some risks, but studies confirm it's safe when done properly.

Intrathecal administration means injecting cells into the fluid around the spinal cord. This method spreads cells more widely and isn't as invasive as direct spinal injections. Research suggests multiple treatments work better than just one.

Intravenous delivery offers the gentlest approach but faces one big challenge: cells struggle to cross the blood-brain barrier. Still, this method has improved conditions in mice with ALS.

A new technique called subpial delivery shows real promise. Doctors inject cells between the pial membrane and outer spinal cord layers. Animal studies show these cells spread throughout the spinal cord without touching nerve tissues directly. This could make the procedure safer.

Stem cell therapy for ALS looks promising, but we have a long way to go. The FDA hasn't approved any treatments outside clinical trials yet. Scientists keep working to refine these approaches. Their goal? To develop treatments that could change how we fight this challenging neurodegenerative disease.

Read MORE Read Less

Can Stem Cells Cure ALS? Examining the Evidence

“Among the 26 patients, 87% were defined as responders to either ALS Functional Rating Scale-Revised or forced vital capacity, having at least 25% improvement at six months after treatment in the slope of progression.” — Panayiota Petrou, Senior Neurologist at Hadassah Medical Center

Scientists still ask if stem cells can cure ALS. Clinical trials worldwide give us a clear picture of what these treatments can and cannot do in the quest for an ALS cure.

Current Clinical Trial Results

Early-phase stem cell trials focus mainly on safety checks. Note that several studies confirm stem cell therapy is generally safe for ALS patients.

A groundbreaking study showed that doctors could safely inject bone marrow stem cells into a patient's cerebrospinal fluid with no major side effects. The trial also reported no serious problems in 18 patients who received stem cells engineered to produce GDNF.

Side effects do happen, though. A recent Phase 2 trial found that almost half the patients had moderate to severe reactions. Pain was common - 23 patients reported significant back pain, limb pain, or headache. The good news is most discomfort went away within 1-2 weeks. This led researchers to call the treatment "reasonably well tolerated."

Some trials have shown promising results. One study found that 13 out of 20 patients had better disease progression rates after MSC therapy. Yes, it is worth noting that another trial showed that 6 out of 19 patients lived longer and had slower disease progression during a 9-year follow-up.

Measuring Success: What Improvements are Possible

ALS stem cell clinical trials use standard ways to measure success. The ALS Functional Rating Scale-Revised (ALSFRS-R) helps track how well patients can function. Doctors also check breathing ability through forced vital capacity (FVC) tests. Patient survival time tells us the most about treatment success.

The best results come from treatments that slow down the disease. Some patients respond exceptionally well. One recent study found that 21 out of 57 patients had at least 25% slower ALSFRS-R decline after MSC treatment. Another analysis showed patients getting MSC transplants lived an average of 118.8 months—almost 10 years—compared to the expected 70.79 months.

Physical improvements include:

Boosted neuromuscular connections
Partial recovery of motor functions
Better quality of life
Slower disease progression in responding patients

Limitations of Current Treatments

Big challenges still exist. The FDA hasn't approved any stem cell therapy for ALS outside clinical trials. Many studies show treatments work no better than placebos. While some patients get better, others see no change or get worse.

Right now, doctors struggle to predict which patients will respond to treatment. Cellular therapy affects ALS patients differently. Research now focuses on finding biomarkers that might show who will benefit.

Treatment benefits don't always last. Many patients' conditions start getting worse again, suggesting they might need repeated treatments. The risks of intraspinal or intracortical injections must be carefully weighed against possible benefits.

Timing might be the biggest hurdle. Stem cells mainly protect the remaining motor neurons instead of replacing dead ones. One researcher put it simply: "If all the motor neurons are dead, no matter how much progenitor cells and GDNF we deliver, they've got nothing to act on."

The research community stays cautious: stem cell therapy looks promising to slow ALS progression in some patients. However, calling it a "cure" would be premature based on current evidence. The question "Will there be a cure for ALS?" remains open, driving ongoing research efforts.

Read MORE Read Less

Comparing Treatment Options for ALS Patients

ALS patients looking beyond standard medicine often search desperately to find treatments that work. The severity of ALS and limited options push them to explore every possible way to manage their condition.

Conventional Treatments vs. Stem Cell Therapy

The FDA-approved ALS medications don’t offer much hope. Riluzole adds only 2-3 months to life expectancy. Edaravone works better for patients in the early stages. The latest approved drug, sodium phenylbutyrate/taurursodiol (Relyvrio), helps patients live about 6.5 months longer.

Stem cells for ALS therapies take a different approach than standard treatments that focus on symptoms. These therapies target the disease mechanisms that cause the condition through multiple pathways.

Read MORE Read Less

Inside Regencord: What Makes Their ALS Protocol Different

Regencord has developed specialized protocols that distinguish their approach from mainstream ALS treatments. Their methods align with state-of-the-art developments in regenerative medicine research, showing promise for this challenging condition.

Proprietary Treatment Methods

Regencord’s approach focuses on neural progenitors engineered to express glial cell-derived neurotrophic factor (GDNF) – a powerful growth factor that protects neurons from degeneration. The specialized stem cells are implanted directly into the lumbar spinal cord through precise ALS surgery. This targeted delivery will give the therapeutic cells direct access to the area controlling leg movement, which maximizes benefits.

Read MORE Read Less

The Patient Experience: From Consultation to Post-Treatment

Patients who want stem cell transplants for ALS at Regencord start a well-laid-out trip that aims to get the best results. Their detailed pathway has evaluation, individual-specific treatment, and continuous care.

Original Evaluation Process

Treatment begins with a detailed consultation where medical specialists review each patient’s condition. Doctors look at existing medical reports and previous studies to see how stem cell therapy might help. The health administration team gets a full picture of the patient’s current health status to check if they qualify. Specialists use this information to create a treatment plan that fits the specific needs of the ALS patient.

Read MORE Read Less

Conclusion

Stem cell therapy offers ALS patients new hope for treatment, but it works best when combined with other care approaches instead of being used alone. Research shows promising results that slow down the disease’s progression. Success depends on choosing the right patients and setting realistic goals.

The protocol at Regencord’s facility in Pereira delivers excellent results. They combine cutting-edge cell therapy with close patient monitoring and complete support systems. ALS patients find this facility attractive because of their proven track record and lower costs than Western clinics.

ALS treatment’s future will likely combine different therapies, and stem cell treatment will play a bigger role. We have a long way to go, but we can build on this progress as researchers keep improving treatment methods to help patients battle this tough neurodegenerative disease. Schedule a consultation with Regencord and experience the difference!

FAQs

Arthritis in Hands Treatment

3-Step Process for Stem Cell Treatment for Arthritis in Hands

Stem Cells for ALS Treatment